An engineered probiotic co-expressing dual melanoma epitopes for therapeutic cancer vaccination
{{output}}
Therapeutic cancer vaccines face challenges in tumor targeting, adjuvant dependency, and inefficient antigen cross-presentation. We engineered a probiotic vaccine using Escherichia coli Nissle 1917 co-expressing MHC-I epitopes from melanoma antigens Pmel17 and... ...
